Cryo-Cell InternationalNASDAQ: CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Cryo-Cell International is in the Healthcare sector

Cryo-Cell International is in the Medical Care Facilities industry

Cryo-Cell International is headquartered in United States

Cryo-Cell International initial public offering (IPO) was on 04 April 1994

https://www.cryo-cell.com

No, Cryo-Cell International is not included in the S&P 500 index

No, Cryo-Cell International is not included in the NASDAQ 100 index

No, Cryo-Cell International is not included in the Dow Jones index

No data